Amyloidosis trials in Canada

3 of 11 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

  Where

  Halifax, London, Montreal, Rimouski, Toronto, Vancouver

  Age

  18 years to 130 years

  People

  1,850 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06465810
• No phaseTaking people
  Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations

  Where

  Vancouver

  Age

  18 years and over

  People

  320 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07654855
• No phaseTaking people
  OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

  Where

  Calgary

  People

  52,121 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06355934